It is not known whether the absence of significant associations between funding source, trial outcome and reporting quality reflects a true absence of an association or is an artefact of inadequate statistical power, reliance on voluntary disclosure of funding information, a focus on trials recently published in the top medical journals, or some combination thereof. Continued and expanded monitoring of potential conflicts is recommended, particularly in light of new guidelines for disclosure that have been endorsed by the ICMJE.
Mohammed Kashif Al-Ghita, Kelly D. Cobey, David Moher, Mariska Leeflang, Sanam Ebrahimzadeh, Eric W.‐F. Lam, Paul Rooprai, Ahmed Al Khalil, Nabil Islam, Hamza Algodi, Haben Dawit, Robert G. Adamo, Mahdi Zeghal, Matthew D. F. McInnes
Phi‐Yen Nguyen, Raju Kanukula, Joanne E. McKenzie, Zainab Alqaidoom, Sue Brennan, Neal Haddaway, Daniel G. Hamilton, Sathya Karunananthan, Steve McDonald, David Moher, Shinichi Nakagawa, David Nunan, Peter Tugwell, Vivian Welch, Matthew J. Page
Discussion(0)
No comments yet. Be the first to comment.